Loading chart...
PODDPODD
$148.80Up 0.28 percent, +$0.41
As of today at 12:56 PM ET
Key Stats
Market Cap$10.291B
Volume (24h)383,205
Day's Range$147.24-$151.46
52-Week Range$126.40-$354.88
PE Ratio108.61
EPS1.37
Net Income (FY)$247.10M
Revenue (FY)$2.71B
About Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.
- Website
- insulet.com
- Industry
- SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
- Full-time Employees
- 5,400
- Headquarters
- ACTON
- IPO Date
- May 15, 2007
| 24 hours | 5 days | 1 month | YTD | 1 year | All time |
|---|---|---|---|---|---|
Up 0.28 percent | Up 3.75 percent | Down 10.01 percent | Down 48.16 percent | Down 56.22 percent | Up 832.30 percent |